ATE223379T1 - N-aryloxyethylaminderivate zur behandlung der depression - Google Patents

N-aryloxyethylaminderivate zur behandlung der depression

Info

Publication number
ATE223379T1
ATE223379T1 AT99915318T AT99915318T ATE223379T1 AT E223379 T1 ATE223379 T1 AT E223379T1 AT 99915318 T AT99915318 T AT 99915318T AT 99915318 T AT99915318 T AT 99915318T AT E223379 T1 ATE223379 T1 AT E223379T1
Authority
AT
Austria
Prior art keywords
hydrogen
halogen
lower alkyl
depression
treatment
Prior art date
Application number
AT99915318T
Other languages
English (en)
Inventor
Richard Eric Mewshaw
Dahui Zhou
Ping Zhou
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE223379T1 publication Critical patent/ATE223379T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99915318T 1998-04-08 1999-04-07 N-aryloxyethylaminderivate zur behandlung der depression ATE223379T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5730798A 1998-04-08 1998-04-08
PCT/US1999/007622 WO1999051576A1 (en) 1998-04-08 1999-04-07 N-aryloxyethylamine derivatives for the treatment of depression

Publications (1)

Publication Number Publication Date
ATE223379T1 true ATE223379T1 (de) 2002-09-15

Family

ID=22009801

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99915318T ATE223379T1 (de) 1998-04-08 1999-04-07 N-aryloxyethylaminderivate zur behandlung der depression

Country Status (11)

Country Link
EP (1) EP1068184B1 (de)
JP (1) JP2002510676A (de)
CN (1) CN1160332C (de)
AT (1) ATE223379T1 (de)
AU (1) AU3386299A (de)
CA (1) CA2327303A1 (de)
DE (1) DE69902766T2 (de)
DK (1) DK1068184T3 (de)
ES (1) ES2182509T3 (de)
PT (1) PT1068184E (de)
WO (1) WO1999051576A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003513970A (ja) * 1999-11-08 2003-04-15 ワイス 中枢神経系障害の治療のための［（インドール−３−イル）−シクロアルキル］−３−置換アゼチジン
DE10006139A1 (de) * 2000-02-11 2001-08-16 Merck Patent Gmbh Indol-3-yl-Derivate
MXPA03008807A (es) 2001-03-29 2004-02-12 Bristol Myers Squibb Co Derivados de ciclopropilindol como inhibidores selectivos de recaptacion de serotonina.
US7041697B2 (en) * 2002-09-12 2006-05-09 Wyeth Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
DE10305739A1 (de) * 2003-02-11 2004-08-19 Merck Patent Gmbh Benzofuranderivate
DE10306941A1 (de) * 2003-02-18 2004-08-26 Merck Patent Gmbh Benzofuranoxyethylamine
DE102006033109A1 (de) 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
WO2009128088A2 (en) * 2008-04-15 2009-10-22 Shodhana Laboratories Limited Preparation of 2-(2-alkoxy phenoxy) ethylamine, an intermediate of carvedilol and tamsulosin
CN112358450A (zh) * 2020-11-19 2021-02-12 南京艾康生物科技有限公司 一种4-(苄氧基)-2-甲基-1H-苯并[d]咪唑-6-羧酸的合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468882A (en) * 1966-10-07 1969-09-23 Sterling Drug Inc Phenylhydrazone derivatives as intermediates for preparing indoles
US3371098A (en) * 1966-11-29 1968-02-27 Philips Corp 5- and 6-methoxy-3-(phenoxyethyl-aminoethyl)-indoles
DE2827874A1 (de) * 1978-06-24 1980-02-07 Merck Patent Gmbh Indolalkylamine und verfahren zu ihrer herstellung
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
US5124332A (en) * 1991-01-28 1992-06-23 Warner-Lambert Company Substituted indoles as central nervous system agents
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
JPH05125024A (ja) * 1991-11-05 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアリールオキシアルキルアミン誘導体又はその塩
US5314896A (en) * 1991-11-20 1994-05-24 Warner-Lambert Company 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
JPH05255302A (ja) * 1992-03-09 1993-10-05 Yamanouchi Pharmaceut Co Ltd 新規なクロマニルオキシアルキルアミン誘導体
IT1271352B (it) * 1993-04-08 1997-05-27 Boehringer Ingelheim Italia Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
US5436264A (en) * 1993-08-19 1995-07-25 Syntex (U.S.A.) Inc. N-aryloxyalkyl tryptamine α1 -adrenergic receptor antagonists
US5468767A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
JPH0940648A (ja) * 1995-08-02 1997-02-10 Yamanouchi Pharmaceut Co Ltd 新規な８−（２−アミノアルコキシ）キノリン誘導体
EP0923551B1 (de) * 1996-08-27 2002-06-05 American Home Products Corporation 4-aminoethoxy-indolon-derivate
ATE234281T1 (de) * 1996-08-27 2003-03-15 Wyeth Corp 4-aminoethoxy-indolderivate als dopamin d2 agonisten und als 5ht1a liganden

Also Published As

Publication number Publication date
ES2182509T3 (es) 2003-03-01
WO1999051576A1 (en) 1999-10-14
PT1068184E (pt) 2002-12-31
CA2327303A1 (en) 1999-10-14
EP1068184B1 (de) 2002-09-04
CN1160332C (zh) 2004-08-04
CN1303373A (zh) 2001-07-11
EP1068184A1 (de) 2001-01-17
DK1068184T3 (da) 2002-12-30
DE69902766D1 (de) 2002-10-10
AU3386299A (en) 1999-10-25
JP2002510676A (ja) 2002-04-09
DE69902766T2 (de) 2003-02-06

Similar Documents

Publication Publication Date Title
ATE283268T1 (de) 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
DE59600105D1 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Tinnitus
HUP9904361A2 (hu) Izobutil-gaba és származékai alkalmazása fájdalom kezelésére
ATE223379T1 (de) N-aryloxyethylaminderivate zur behandlung der depression
FI923540A0 (fi) Arylalkylaminer och -amider med antikonvulsiva och nervskyddande egenskaper.
DK0783495T3 (da) Quinoxalinderivater, der er egnede i terapi
DK0724584T3 (da) Heterocycliske aminer med CNS-virkning
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
ATE250027T1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
ATE279925T1 (de) Verwendung von halofuginon zur herstellung eines medikaments zur vorbeugung von neovaskularisation und zur behandlung bösartiger tumore
CO5040091A1 (es) Derivados de urea
ATE181503T1 (de) Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
DE69906728D1 (de) Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
NO994343D0 (no) Anvendelse av 2,3,4,5 - tetrahydro- 1H-3-benzazepiner for fremstilling av en farmasöytisk blanding for behandlingen av soveuregelmessigheter
HUP0001637A2 (hu) Görcsoldó hatású származékok alkalmazása psoriasis kezelésére használható gyógyszerkészítmények előállítására
ATE264840T1 (de) Azetidincarboxamid-derivate zur behandlung von zns störungen
DE69902142D1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
DE60000405D1 (de) 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression
ATE227718T1 (de) N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen
ATE195422T1 (de) Verwendung von piperazinderivaten zur behandlung von kognitiven erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1068184

Country of ref document: EP

REN Ceased due to non-payment of the annual fee